Tuesday, August 4, 2026

May CPI Surge: What It Means for U.S. Interest Rates and Asian Markets

Global markets brace for U.S. CPI report amid rising inflation from energy prices, with Fed rate hikes anticipated later this year.

U.S. pharmaceutical companies’ China clinical trial security probe to conclude this week… Could biotech rivalry intensify?

A U.S. investigation into pharmaceutical trials in China may reshape global biotech strategies, impacting South Korean firms.

THE SPY IN THE INNER CIRCLE : Has A South Korean Asset Infiltrated Pyongyang’s Second Tier?!

Ri Son-gwon has been appointed chairman of North Korea's KSDP, indicating a shift in his political influence and focus.

Health

Hong Seong-ho of Seoul St. Mary’s Hospital Becomes First in Asia-Pacific to Perform 1,000 Single-Port Robotic Urologic Surgeries

A South Korean medical team achieved 1,000 single-port robotic surgeries in urology, led by Professor Hong Seong-ho.

Celltrion accelerates mechanism diversification strategy, expands autoimmune disease portfolio

Celltrion accelerates the development of biosimilars for autoimmune disease treatments, expanding its portfolio for long-term growth.

South Korea’s first single-port robotic gallbladder surgery study confirms safety

A study shows single-port robotic gallbladder surgery is faster than traditional laparoscopic methods while maintaining safety, promising less scarring.

Lunit Expands Global Reach: New AI Solutions for Breast Cancer Screening in the UK and U.S.

Lunit expands its global supply chain by securing contracts with major healthcare institutions in the UK and U.S. for AI solutions.

Penetrium Bio to unveil U.S. Phase 2 strategy at global symposium

Penetrium Bio will unveil its Phase 2 clinical development strategy for the next-gen cancer drug Penetrium at a global symposium next month.
Latest

Alpha Tau Medical’s Alpha DaRT: A New Hope for Pancreatic Cancer Patients – What You Need to Know

Alpha Tau Medical will present clinical results of its DaRT technology for pancreatic cancer at DDW 2026, marking a significant milestone.

How Vieworks Plans to Boost Shareholder Value with 12.4% Dividend Increase in 2026

Vieworks plans to enhance corporate value through growth strategies, increased dividends, and share buybacks to boost shareholder returns.

Discover the Future of Heart Care: Medtronic’s Micra2 Pacemaker Launches with 40% Longer Battery Life

Medtronic launched the Micra 2 leadless pacemaker, enhancing battery life and algorithms for personalized cardiac care.

How AI Read CXR is Transforming Chest X-Ray Analysis: A Deep Dive into the First AI Medical Device Approved in Korea

South Korea's first generative AI medical device, AI Read X-ray, gains approval for interpreting X-rays with radiologist-level accuracy.

Pangen Expands Cell-Based Bioassay Services for Customized Drug Development

Pangen is expanding its cell-based activity analysis services after a new contract, enhancing drug evaluation capabilities for various medications.

Lunit’s AI Foundation Model: Transforming Healthcare with 16 Billion Parameters

Medical AI firm Lunit successfully passes the first phase of a national project and enters the second phase of nationwide validation.

Hanmi Pharmaceutical’s Leadership Shake-Up: What Does New CEO Hwang Sang-yeon Mean for the Future?

Hanmi Pharmaceutical Group's management dispute appears to be resolved, marking its first external leadership in 53 years.

Hugel Partners with Hansbiomed: What Does the New ECM Product CellREDM Mean for Your Skin?

Hugel partners with HansBiomed to distribute CellREDM, enhancing skin regeneration and expanding its product portfolio in medical aesthetics.

Exploring Cenobamate: How SK Biopharmaceuticals’ New Oral Suspension Benefits Adult Epilepsy Patients

SK Biopharmaceuticals submits NDA for Cenobamate oral suspension, enhancing treatment options for epilepsy patients with swallowing difficulties.

Unlocking the Future of Cancer Treatment: UCI-101 CAR-NK Therapy by UCI Therapeutics

Matica BioLabs partners with UC Therapeutics to manufacture CAR-NK cell therapy, enhancing cancer treatment through dual-targeting technology.

2025 Healthcare Survey: How Many Koreans Skip Medical Visits Due to Costs?

A survey shows financial barriers minimally affect healthcare access, with high outpatient usage and patient satisfaction reported.

How a New MOU is Transforming Health Services for Local Businesses in Gangneung

A regional medical center and chamber of commerce have partnered to enhance healthcare access for local business members and families.

Top 5 Warning Signs of Lung Disease: Are You at Risk?

Dr. Lee Eun-ju emphasizes the importance of lung health, warning against ignoring symptoms like breathlessness and advocating for screenings.

Unlocking Genetic Insights: Family Insight Test Launches for High-Risk Families in Asia

3billion launches the Family Insight Test, a genomic diagnostic tool for high-risk families, enhancing genetic risk assessment and family planning.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.